Literature DB >> 30247363

ACOG Committee Opinion No. 754: The Utility of and Indications for Routine Pelvic Examination.

.   

Abstract

The pelvic examination has long been considered a fundamental component of the well-woman visit, and many women and gynecologic care providers view this visit as an opportunity to discuss sexual and reproductive health issues. Traditionally, a pelvic examination is performed for asymptomatic women as a screening tool for gynecologic cancer, infection, and asymptomatic pelvic inflammatory disease; some obstetrician-gynecologists and patients consider it important in detecting subclinical disease, despite evidence to the contrary. Given changes in screening recommendations and the ability to screen for sexually transmitted infections using less-invasive methods, reevaluation of the role of the pelvic examination for asymptomatic, nonpregnant women is warranted. A limited number of studies have evaluated the benefits and harms of a screening pelvic examination for detection of ovarian cancer, bacterial vaginosis, trichomoniasis, and genital herpes. Data from these studies are inadequate to support a recommendation for or against performing a routine screening pelvic examination among asymptomatic, nonpregnant women who are not at increased risk of any specific gynecologic condition. It is recommended by the American College of Obstetricians and Gynecologists that pelvic examinations be performed when indicated by medical history or symptoms. Women with current or a history of cervical dysplasia, gynecologic malignancy, or in utero diethylstilbestrol exposure should be screened and managed according to guidelines specific to those gynecologic conditions. Based on the current limited data on potential benefits and harms and expert opinion, the decision to perform a pelvic examination should be a shared decision between the patient and her obstetrician-gynecologist or other gynecologic care provider.

Entities:  

Mesh:

Year:  2018        PMID: 30247363     DOI: 10.1097/AOG.0000000000002895

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Rapid recommendations: Updates from 2019 guidelines: part 2.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2020-06       Impact factor: 3.275

2.  Consent for the Pelvic Examination Under Anesthesia by Medical Students: Recommendations by the Association of Professors of Gynecology and Obstetrics.

Authors:  Maya M Hammoud; Kayte Spector-Bagdady; Meg OʼReilly; Carol Major; Laura Baecher-Lind
Journal:  Obstet Gynecol       Date:  2019-12       Impact factor: 7.661

Review 3.  Addressing Anxiety and Fear during the Female Pelvic Examination.

Authors:  Danielle J O'Laughlin; Brittany Strelow; Nicole Fellows; Elizabeth Kelsey; Sonya Peters; Joy Stevens; Johanna Tweedy
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

4.  Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.

Authors:  Jason D Wright; Ling Chen; Ana I Tergas; Alexander Melamed; Caryn M St Clair; June Y Hou; Fady Khoury-Collado; Allison Gockley; Melissa Accordino; Dawn L Hershman
Journal:  JAMA Netw Open       Date:  2021-04-01

5.  Delayed Visits for Contraception Due to Concerns Regarding Pelvic Examination Among Women with History of Intimate Partner Violence.

Authors:  Hunter K Holt; George F Sawaya; Alison M El Ayadi; Jillian T Henderson; Corinne H Rocca; Carolyn L Westhoff; Cynthia C Harper
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 6.473

6.  Performance and acceptability of self-collected human papillomavirus testing among women living with HIV.

Authors:  Runzhi Wang; Kristen Lee; Charlotte A Gaydos; Jean Anderson; Jean Keller; Jenell Coleman
Journal:  Int J Infect Dis       Date:  2020-07-30       Impact factor: 3.623

7.  Association of Insurance Status With Provision of Recommended Services During Comprehensive Postpartum Visits.

Authors:  Kimberley Geissler; Brittany L Ranchoff; Michael I Cooper; Laura B Attanasio
Journal:  JAMA Netw Open       Date:  2020-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.